Connor, Clark & Lunn Investment Management (CC&L)’s NextCure NXTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
2022
Q3
$264K Buy
2022
Q2
$310K Buy
2022
Q1
$232K Sell
2021
Q4
$300K Buy
2021
Q3
$99K Buy